5-chloro-1-(4-chlophenylsulfenyl)methyl-2(1H)-pyrimidinone | 83767-86-6

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 5-chloro-1-(4-chlophenylsulfenyl)methyl-2(1H)-pyrimidinone
• 英文别名: 1-(4-chlorophenylsulphenyl) methyl-5-chloropyrimidin-2-one；1-(4-Chlorophenylsulfenyl)methyl-5-chloropyrimidin-2-one；5-chloro-1-[(4-chlorophenyl)sulfanylmethyl]pyrimidin-2-one
• CAS: 83767-86-6
• 化学式: C₁₁H₈Cl₂N₂OS
• 分子量: 287.169
• InChiKey: CWGAFCGAEXBDNZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  58
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-chloro-1-(4-chlophenylsulfenyl)methyl-2(1H)-pyrimidinone 在 2,3-二氯-5,6-二氰基-1,4-苯醌 作用下， 以 四氢呋喃 、 乙醚 、 苯 为溶剂， 反应 36.0h， 生成 5-chloro-1-(4-chlorophenylthiomethyl)-4-phenylpyrimidin-2(1H)-one
  参考文献：
  名称：

  Rise, Frode; Undheim, Kjell, Journal of the Chemical Society. Perkin transactions I, 1985, p. 1997 - 2000

  摘要：

  DOI：
• 作为产物：
  描述：

  2-羟基-5-氯嘧啶 、 对氯苯氯甲基硫醚 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 生成 5-chloro-2-(4-chlorophenylsulfenyl)methyloxypyrimidine 、 5-chloro-1-(4-chlophenylsulfenyl)methyl-2(1H)-pyrimidinone
  参考文献：
  名称：

  α-卤代硫化物在2-嘧啶酮的烷基化中

  摘要：

  当α-卤代硫化物与环境2-嘧啶酮反应时，主要产物是由于N-烷基化，次要产物是O-烷基化。通过在低介电常数的溶剂中存在叔胺，以及通过将α-卤代硫化物取代基从氯变为碘来促进N-烷基化。可以实现完全的选择性。根据HSAB原理，反应过程是合理的。

  DOI：

  10.1002/jhet.5570220430

文献信息

• Substituted pyrimidin-2-ones and the salts thereof
  申请人：Nyegaard & Co. A.S.

  公开号：US04596870A1

  公开（公告）日：1986-06-24

  Compounds of the general formula: ##STR1## (wherein X represents a halogen atom or a trifluoromethyl group; R.sup.1 and R.sup.2 independently represent a hydrogen atom or a lower alkyl group; Z is --O--, --S--, --SO--, --SO.sub.2 -- or the group --NR.sup.4 -- wherein R.sup.4 is as defined for R hereinafter or represents the group COR.sup.5 in which R.sup.5 represents a hydrogen atom or an optionally substituted aryl, heterocyclic, aralkyl, lower alkyl or lower alkoxy group; R represents a C.sub.6-10 carbocyclic aromatic group or a heterocyclic group containing a 5-9 membered unsaturated or aromatic heterocyclic ring which ring contains one or more heteroatoms selected from O, N and S and optionally carries a fused ring which carbocyclic or heterocyclic group may carry one or more C.sub.1-4 alkyl or phenyl groups, said groups being optionally substituted; or, where Z represents the group >NR.sup.4, the group --ZR may represent a heterocyclic ring optionally carrying a fused ring and/or optionally substituted as defined for R; and R.sup.3 represents a hydrogen atom or a lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower alkenoyl, C.sub.7-16 aralkyl or C.sub.6-10 arly group or a 5-9 membered unsaturated or aromatic heterocyclic ring); and, where acid or basic groups are present, the salts thereof; are useful in combating abnormal cell proliferation. The compounds of the invention are prepared by inter alia alkylation, ring closure and oxidation.

  通式为：##STR1## 的化合物（其中X代表卤素原子或三氟甲基基团；R.sup.1和R.sup.2分别代表氢原子或较低的烷基基团；Z为--O--，--S--，--SO--，--SO.sub.2 --或基团--NR.sup.4 --其中R.sup.4如下所定义或代表基团COR.sup.5，其中R.sup.5代表氢原子或可选择取代的芳香族、杂环、芳基烷基、较低的烷基或较低的烷氧基团；R代表C.sub.6-10碳环芳族或含有5-9个成员的不饱和或芳香杂环环，该环含有O、N和S中选定的一个或多个杂原子，并且可选择携带一个融合环的碳环或杂环基团，该碳环或杂环基团可以携带一个或多个C.sub.1-4烷基或苯基基团，这些基团可选择取代；或者，Z代表基团>NR.sup.4时，基团--ZR可以代表一个可选择携带一个融合环和/或可选择取代的杂环环，如R所定义；R.sup.3代表氢原子或较低的烷基、较低的烯基、较低的炔基、较低的烷酰基、较低的烯酰基、C.sub.7-16芳基烷基或C.sub.6-10芳基基团或一个5-9成员的不饱和或芳香杂环环）；并且，如有酸性或碱性基团存在，其盐；在对抗异常细胞增殖方面是有用的。该发明的化合物是通过烷基化、环闭合和氧化等方法制备的。
• Pyrimidinones as reversible metaphase arresting agents
  作者：T Benneche、P Strande、R Oftebro、K Undheim

  DOI：10.1016/0223-5234(93)90014-6

  日期：1993.1

  5-Halo-N(1)-substituted 2(1H)-pyrimidinones have the ability to cause reversible arrest of mitosis during metaphase, Highly active compounds have a heteroatom (O, S or N) in the beta-position of the N(1)-carbon chain which is further substituted by an aryl group. In vitro data have been provided. It is suggested that reversible metaphase inhibitors can be used as synchronizing agents of cell-cycles by applying them in a sequential manner when a phase-specific cytotoxic drug is used in the treatment of diseases caused by uncontrolled rapidly proliferating cells. The active compounds are prepared from 2-pyrimidinones by alkylation reactions. The key reactants are alpha-chloroalkyl ethers, sulfides and amides; methods for their syntheses have been described.
• Sodium 2-Mercaptoethanesulfonate in Reversible Adduct Formation and Water Solubilization.
  作者：Frode Rise、Kjell Undheim、Peder Kierkegaard、Janina Legendziewicz、Ewa Huskowska、Lija Tekenbergs-Hjelte、Kristina Ohlson、Tomas Alminger、Magnus Erickson、Inger Grundevik、Inger Hagin、Kurt-Jürgen Hoffman、Svante Johansson、Sam Larsson、Ingalil Löfberg、Kristina Ohlson、Björn Persson、Inger Skånberg、Lija Tekenbergs-Hjelte

  DOI：10.3891/acta.chem.scand.43-0489

  日期：——

  Sodium 2-mercaptoethanesulfonate (MESNA, coenzyme M) forms 1:1 covalent adducts with highly pi-electron deficient heterocycles. The addition is caused by the thiol function, and the adducts become water soluble as sulfonates. 1H NMR spectroscopy has been used to obtain information about electronic and steric effects on the equilibria between 2-pyrimidinones and their 1:1 MESNA adducts. The adducts are potential prodrugs for biologically interesting 2-pyrimidinones.
• RISE, FRODE;UNDHEIM, KJELL, ACTA CHEM. SCAND., 43,(1989) N, C. 489-492
  作者：RISE, FRODE、UNDHEIM, KJELL

  DOI：——

  日期：——
• STRANDE, PER;BENNECHE, TORE;UNDHEIM, KJELL, J. HETEROCYCL. CHEM., 1985, 22, N 4, 1077-1080
  作者：STRANDE, PER、BENNECHE, TORE、UNDHEIM, KJELL

  DOI：——

  日期：——